Laura Mezquita - Researcher Profile | RDL Research Database

Publications

2 shown

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres , Alexander Drilon , Amélie Lusque +35 more

2019 Annals of Oncology 1292 citations

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

Kathryn C. Arbour , Laura Mezquita , Niamh M. Long +16 more

Purpose Treatment with programmed cell death-1 or programmed death ligand 1 (PD-(L)1) inhibitors is now standard therapy for patients with lung cancer. The immunosuppressive eff...

2018 Journal of Clinical Oncology 1004 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,296
Institution: Institut Gustave Roussy

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0936-7338

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.